Clinical Trial Update: Solriamfetol for the Treatment of Multiple Sclerosis Fatigue [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating solriamfetol for fatigue in individuals with multiple sclerosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Multiple Sclerosis Fatigue

Drugs mentioned

• Solriamfetol (solriamfetol)

Snippet

Sponsor: Johns Hopkins University | Conditions: Multiple Sclerosis, Multiple Sclerosis Fatigue | Phase 2 | Status: RECRUITING